Navigation Links
Oncolytics Biotech Inc. Announces Gene Therapy Publication on Reovirus Treatment for Melanoma
Date:4/16/2008

ing delivery of REOLYSIN(R), and the Company's belief as to the potential of REOLYSIN(R) as a cancer therapeutic, involve known and unknown risks and uncertainties, which could cause the Company's actual results to differ materially from those in the forward-looking statements. Such risks and uncertainties include, among others, the availability of funds and resources to pursue research and development projects, the efficacy of REOLYSIN(R) as a cancer treatment, the success and timely completion of clinical studies and trials, the Company's ability to successfully commercialize REOLYSIN(R), uncertainties related to the research and development of pharmaceuticals and uncertainties related to the regulatory process. Investors should consult the Company's quarterly and annual filings with the Canadian and U.S. securities commissions for additional information on risks and uncertainties relating to the forward-looking statements. Investors are cautioned against placing undue reliance on forward-looking statements. The Company does not undertake to update these forward-looking statements.


'/>"/>
SOURCE Oncolytics Biotech Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Oncolytics Biotech Inc. Collaborators Present Reovirus Research for Multiple Myeloma at AACR Annual Meeting
2. Oncolytics Biotech Inc. Collaborators Present Reovirus Research for Pediatric Sarcomas at AACR Annual Meeting
3. Oncolytics Biotech Inc. Completes Dose Escalation in Combination REOLYSIN(R)/Paclitaxel and Carboplatin Trial
4. Oncolytics Biotech Inc. Reports Positive Interim Results of U.K. Combination REOLYSIN(R) and Carboplatin/Paclitaxel Trial
5. Oncolytics Biotech Inc. Announces Issuance of 26th U.S. Patent
6. Oncolytics Biotech Inc. Announces Publication of Research on Immune Response to REOLYSIN(R) during a Phase I Clinical Trial
7. Oncolytics Biotech Inc. Collaborators to Present Reovirus Research at AACR Annual Meeting
8. Media Advisory - Oncolytics Biotech Inc. to Present at BioSquare 2008
9. Oncolytics Biotech Inc. Reports Highlights and Financial Results for 2007
10. Media Advisory - Oncolytics Biotech Inc. to Present at Bio CEO & Investor Conference
11. Oncolytics Biotech Inc. Announces Publication of Research on Combination Reovirus and Radiation Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... 2015 The consumption of compound fertilizers ... recession and high prices in 2008. However, the situation ... keeps on gaining momentum now. , To date, the ... than 100,000 thousand tonnes. No considerable growth was registered ... capacity rocketed during 2012-2013, registering 11% growth as against ...
(Date:3/27/2015)... , March 27, 2015 Working ... Free Hospital in London , Richmond Pharmacology ... a global Phase 3 study for an investigational RNAi therapeutic ... orphan disease affecting the nerves and heart. ... Detail Based at St Georges University of ...
(Date:3/26/2015)... PRC Clinical, a Silicon-Valley based contract ... executive appointments effective immediately. , Mike Catelani will assume ... of the Board of Directors. Daniel Head is appointed ... will assume the position of Senior Director of Clinical ... (COO), has been appointed to the position of President ...
(Date:3/26/2015)... Neogen Corporation (NASDAQ: NEOG ) announced today that ... 2015, which ended Feb. 28, increased 13% to $7,454,000, ... share in the current quarter were $0.20, compared to ... 17% over prior year to $24,142,000, or $0.65 per ... the same period a year ago. Revenues ...
Breaking Biology Technology:World NPK Fertilizers Market Keeps On Gaining Momentum, According to BAC Reports Study Available at MarketPublishers.com 2World NPK Fertilizers Market Keeps On Gaining Momentum, According to BAC Reports Study Available at MarketPublishers.com 3PRC Clinical Announces Key Management Appointments and Launches East Coast Operations 2PRC Clinical Announces Key Management Appointments and Launches East Coast Operations 3Neogen reports 13% increase in net income 2Neogen reports 13% increase in net income 3Neogen reports 13% increase in net income 4Neogen reports 13% increase in net income 5Neogen reports 13% increase in net income 6Neogen reports 13% increase in net income 7Neogen reports 13% increase in net income 8
... TIKVA, Israel, December 4 Healthcare,Technologies Ltd. (NASDAQ: ... of its unaffiliated and voting shareholders (approximately 90%),voted ... At the meeting, the shareholders were asked to ... Biofuels, Inc, Mac,Bioventures Inc. and Gamida for Life ...
... 4 Biotest Pharmaceuticals,Corporation, a leading developer ... has completed the acquisition of the Nabi,Biopharmaceuticals ... for $185 million,in cash. Biotest Pharmaceuticals is ... the acquisition of the Nabi Biologics product ...
... Maxygen, Inc.,(Nasdaq: MAXY ), a biotechnology company ... today the license of its proprietary,dengue virus antigen ... sanofi-aventis Group., Under the terms of the ... of preclinical dengue antigens for development and,worldwide commercialization ...
Cached Biology Technology:Healthcare Announced That an Overwhelming Majority of its Shareholders Approved the NexGen Biofuels Transaction 2Biotest Pharmaceuticals Corporation Completes Acquisition of Nabi Biologics Business Unit 2Biotest Pharmaceuticals Corporation Completes Acquisition of Nabi Biologics Business Unit 3Maxygen Licenses Dengue Vaccine Technology to sanofi pasteur 2Maxygen Licenses Dengue Vaccine Technology to sanofi pasteur 3
(Date:3/26/2015)... , March 26, 2015 ... family, social, recreation and athletic club, today announced it ... to allow freedom of movement for members and staff, ... "Following a comprehensive process, we selected FST,s IMID Access ... and convenience for our members and staff, in addition ...
(Date:3/24/2015)... , Mar. 24, 2015 Research and Markets ... the "Global Iris Recognition Market 2015-2019" report ... Global Iris Recognition market to grow at a CAGR ... This report covers the present scenario and the growth ... period 2015-2019. To calculate the market size, the report ...
(Date:3/24/2015)... DUBLIN , Mar. 24, 2015 Research and Markets ... "Face and Voice Biometrics - Global Strategic Business Report" report ... for Face and Voice Biometrics in US$ Thousands by the following ... analytics for the US, Canada , ... , Middle East & ...
Breaking Biology News(10 mins):Granite Club First Private Club in North America to Implement FST Biometrics Secure Access Solution, as Part of Multi-million Dollar Expansion 2Global Iris Recognition Market 2015-2019 with 3M Cogent, Bioenable Technologies, Cross Match Technology, Iris ID Systems & Safran Dominating 2Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 2Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 3Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 4Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 5Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 6
... and Building Media Inc. (BMI), a DuPont subsidiary, will ... help dramatically improve the energy efficiency of American homes ... 15 teams, appointed by the U.S. Department of Energy ... million for the initial 18 months to deliver innovative ...
... flu are common occurrences during pregnancy, and research has ... flu, viruses and other infections during pregnancy have about ... A new study out of Temple University examines what,s ... month in Schizophrenia Research , Temple University psychologist ...
... University researchers conducting zooarchaeological and archaeometric analyses of four ... Project in northeastern Ethiopia within walking distance of ... afarensis ) confirm that unusual marks on the ... in on findings reported in the Aug. 12 journal ...
Cached Biology News:NJIT to help lead public/private partnership to develop high-efficiency homes 2Immune responses during pregnancy linked to schizophrenia among offspring 2Immune responses during pregnancy linked to schizophrenia among offspring 3Animal bone markings show evidence that 'Lucy' species used stone tools, ate meat 2Animal bone markings show evidence that 'Lucy' species used stone tools, ate meat 3Animal bone markings show evidence that 'Lucy' species used stone tools, ate meat 4
...
...
Assay Diluent, 10 L...
... Clone/PAD: ZMD.474. Immunogen: Synthetic ... of the mouse junctophilin-3. Specificity: ... the junctophilin-3 protein. Reactivity: Mouse ... mouse hippocampus and heart tissues). ...
Biology Products: